Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy.
Huang C, Li H, Feng Y, Li X, Zhang Z, Jiang C, Wang J, Yang C, Fu Y, Mu M, Zhao S, Wang Z, Kuang Y, Hou H, Wang Y, Guo W, Xu J, Yang H, Zhou L, Tong A, Guo G.
Huang C, et al. Among authors: guo w, guo g.
Theranostics. 2020 Aug 21;10(23):10498-10512. doi: 10.7150/thno.49480. eCollection 2020.
Theranostics. 2020.
PMID: 32929362
Free PMC article.